The assay which goes by the name PUBCHEM_BIOASSAY: Navigating the Kinome and belongs to the class of assays known as 'other,' has a panel member named PDPK1 assigned to it which is a homologous single protein target. This assay is characterized by its assay category which is also 'other,' and its assay type description is 'Functional.' Based on the current context and parameters of the assay, can it be concluded that the molecule exhibits a substantial level of efficacy in regards to this particular examination?